Albiglutide: a new anti-diabetic drug of human glucagon-like peptide analogueCHEN Lan-ting, ZHU Yi-shen, FAN Xue-hai, LI Wen-hui, WEI Ping1969-1972
Phase 0 clinical trials in the development of oncology new drugs in USASHAO Rong, TAO Tian-tian1973-1979
Problems in writing production process in production site inspection of new TCM drugsZHOU Gang, MA Xiu-jing, HAN Wei1980-1983,2007
Development prospects of drug toxicologyWANG Quan-jun, YUAN Ye, MA Hua-zhi, LIAO Ming-yang, WU Chun-qi, DING Ri-gao1984-1989
Progress in the methodological study of in vivo Comet assayOU Hong-mei, ZHOU Chang-hui, TU Hong-gang, CHANG Yan1990-1993
Clinical reaserch development of resistance mechanisms of EGFR-TKIs targeted therapy in patients with non-small cell lung cancerKE E-e, WU Yi-long1994-1998
Development of pharmacogenomics for anti-cancer drugsZHANG Yan, SHI Yuan-kai, HAN Xiao-hong1999-2003,2034
Current research on quantitative detection of biomacromolecule drugsSONG Yuan-yuan, SHI Yuan-kai2004-2007
Current situation and research progress of systemic chemotherapy in the treatment of advanced hepatocellular carcinomaGONG Xin-lei, QIN Shu-kui2008-2017